ENDO: 1999 to 2020 Saw Significant Uptick in Obesity-Related Cancer Deaths
By Elana Gotkine HealthDay Reporter
MONDAY, July 14, 2025 -- From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July 12 to 15 in San Francisco.
Rabbia Haider, M.B.B.S., from St. Luke's Hospital in Ellisville, Missouri, and colleagues analyzed CDC WONDER mortality data for 33,572 obesity-related cancer deaths in 1999 to 2020. Age-adjusted mortality rates (AAMRs) were calculated per million, and trends were examined to determine annual percentage change (APC) and average annual percentage change (AAPC).
The researchers found that from 1999 to 2020, mortality trends increased from an AAMR of 3.73 to 13.52, with 47.7 percent of the deaths occurring in medical facilities. The overall AAPC was 5.92 percent, with a sharp increase noted from 2018 to 2020 (APC, 19.37 percent). The average AAMR was 7.22 for women and 6.59 for men (AAPCs, 5.37 and 6.75 percent, respectively). The highest AAPC was seen in Hispanics, and the lowest in Blacks (6.31 and 5.37 percent, respectively). A significantly higher AAMR was seen in those aged 65 years and older (20.82), peaking at 41.54 in 2020, with an AAPC of 6.26 percent versus those aged 25 to 64 years. The Midwest had the highest AAMR and Northeast had the lowest (7.96 and 5.7, respectively), with AAPCs of 6.01 and 5.56 percent, respectively. Increasing mortality trends were seen in both rural and urban areas (AAPCs, 6.98 and 6.03 percent, respectively).
"This research underscores the need for targeted public health strategies such as early screening and improved access to care, especially in high-risk rural and underserved areas," lead author Faizan Ahmed, M.D., from Duke University Hospital in Brooklyn, New York, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
THURSDAY, Aug. 14, 2025 -- In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August...
Metformin Use Tied to Lower Risk for Dementia, Death in Adults With Overweight, Obesity
TUESDAY, Aug. 12, 2025 -- Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or...
Subspecialization in Oncology Increasingly Utilized
MONDAY, Aug. 11, 2025 -- Subspecialization in oncology is increasing, but varies widely across cancer types and regions, according to a study published online Aug. 12 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.